Skip to main content
. 2019 Dec;19(4):2819–2828. doi: 10.4314/ahs.v19i4.3

Table 2.

Glycaemic control status with demographic and clinical variables in studied patients

Variables N Patient; n (%)

HbA1c (%)
Good control (<7) Poor control (≥7) p-value
23(16.7) 115(83.3)
Demographic
Age(yrs) 138
Non elderly (< 65years) 20(24.7) 61(75.3) 0.005*b
Elderly (≥65years) 3(5.3) 54(94.7)
Sex 138
Male 16(21.1) 60(78.9) 0.193b
female 7(11.3) 55(88.7)
Anthropometric
Body mass Index (BMI) (kg/m2) 138
Underweight/normal (< 25) 3(23.1) 10(76.9) 0.687a
Overweight (25–29.9) 11(14.5) 65(85.5)
Obese (≥ 30) 9(18.4) 40(81.6)
Waist-Hip Ratio (WHR) 137
Low 16(24.6) 49(75.4) 0.034*a
medium 2(10.0) 18(90.0)
high 4(7.7) 48(92.3)
Clinical
Fasting plasma glucose
(FPG)(mmol/l)
138
Within tight control (3.9–7.2) 13(61.9) 8(38.1) 0.001*c
Outside tight control (<3.9 or >7.2) 10(8.5) 107(91.5)
Complications 138
Neuropathy 0(0.0) 2(100.0) 0.181a
Retinopathy 8(21.1) 30(78.9)
Nephropathy 1(3.3) 29(96.7)
Foot amputation/or ulcer 2(13.3) 13(86.7)
Non/unknown 12(22.6) 41(77.4)
Blood pressure
Systolic blood pressure(mmHg) (Mean ± SD) 137.04 ±15.35) 146.11±21.74) 0.021*d
Diastolic blood pressure(mmHg) (Mean ± SD) 86.09 ± 10.76) 88.75 ± 13.65) 0.380d
a

Pearson chi-square test

b

Continuity correction

c

Fisher's exact test

d

Students' t-test

*

statistically significant value (p < 0.05)